CLINICAL_TRIALS
trial_result
· 2016-02-17
Clinical Trial Update: Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II) [Phase 2]
Summary
Phase 2 trial AUGUST II evaluated atacicept in TNF-alpha–naïve rheumatoid arthritis patients; the study is completed and results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-02-17